Delivery Order SPE2DB22D2007-SPE2DB25FJ0CP
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $1,521.95 and a period of performance through April 1, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,394.34. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $13,038.94 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 16, 2024, with a completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,723.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. There is no set-aside designation for this...
This federal contract award from the Defense Logistics Agency (DLA) is for the provision of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to support military healthcare programs. The $12,256.16 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,990.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $29,013.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of October 7, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA). The $36,202.73 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award is for the delivery of COSENTYX 300 mg dose-2 syringes to the Defense Logistics Agency (DLA). The contract, valued at $15,507.06, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, and has an ultimate completion date of March 28, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,212.82 to Amerisourcebergen Drug Corp's Corporate Office Division to provide COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to DLA facilities supporting the Department of Defense. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the...